Abstract
Patients with atrial fibrillation and with documented oartic plaque who were assigned to adjusted-dose warfarin therapy (international normalized ratio 2.0 to 3.0) had an annual rate of cholesterol embolization of 0.7% (95% confidence interval [CI] 0.1% to 5.3%/patient-year). Warfarin-assigned patients with plaque had a lower rate of embolic events (5.9%/year; 95% CI 3.0 to 12) than those on combination low-dose warfarin (international normalized ratio <1.5) plus aspirin (17.3%/year; 95% CI 11 to 27; p = 0.01).
Original language | English (US) |
---|---|
Pages (from-to) | 453-455 |
Number of pages | 3 |
Journal | American Journal of Cardiology |
Volume | 83 |
Issue number | 3 |
DOIs | |
State | Published - Feb 1 1999 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine